Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 31, 2015 15:17:56 GMT -5
While not being at all certain what or when Duane's first big announcement will be (though hoping is a TS deal in Jan), is it fair to think that Matt's job may be on the line due to all that has transpired since notes in summer? Talk about wiping slate clean. Any finance guys wanna chime in on likelihood? i believe so too.. But Matt and Hakan are through Al... and with my experience at work place, a Sr manager joins, he gets his people.. and he goes they mostly leave....but as long as he is there, there is a safety net for his pets
|
|
|
Post by EveningOfTheDay on Jan 3, 2016 8:57:09 GMT -5
I personally would like to see Matt leave, at this point I do not think he has much credibility left with shareholders, but I do not think it will happen any time soon. In any case this would be a good test on how much liberty of action DeSisto is given. To this day my biggest disappointments with Matt have been how disingenuously he has answered questions from investors, and more importantly how he has squandered the chance to rise capital under much better conditions. I guess there is still a chance, due to the fact that we know so little, that we might never see a secondary offering, but at this point I see this as unlikely. In any case the Hakan/Matt team left in place after approval by Mr. Mann has proven extremely inefficient at protecting shareholders interests over the last 17 months. That is certainly undeniable.
|
|
|
Post by mindovermatter on Jan 3, 2016 9:51:20 GMT -5
I personally would like to see Matt leave, at this point I do not think he has much credibility left with shareholders, but I do not think it will happen any time soon. In any case this would be a god test on how much liberty of action DeSisto is given. To this day my biggest disappointment with Matt has been how disingenuously he has answered questions from investors, and more importantly how he has squandered the chance to rise capital under much better conditions. I guess there is still a chance, due to the fact that we know so little, that we might never see a secondary offering, but at this point I see this as unlikely. In any case the Hakan/Matt team left in place after approval by Mr. Mann has proven extremely inefficient at protecting shareholders interests over the last 17 months. If Al has truly handed over the reins to Desisto, don't be surprised if he cleans house starting with the CFO if he thinks Matt isn't up to the task to continue in that position.
|
|
|
Post by EveningOfTheDay on Jan 3, 2016 10:05:31 GMT -5
If Al has truly handed over the reins to Desisto, don't be surprised if he cleans house starting with the CFO if he thinks Matt isn't up to the task to continue in that position. Of course I would expect what you are saying to be true. I guess my point is that, unless there are unknown to us but well understood and aforehead expected reasons on why events have played this way, I would rather have someone else in Matt's position. It remains unclear to me whether he is the right man for the job.
|
|
|
Post by peppy on Jan 3, 2016 10:22:06 GMT -5
I think it was a surprise to both Hakan and Matt, that scripts did not take off. My limited understanding of the structure with sanofi, move manufacturing, set up lines, milestone it turns out the initial orders were for samples and the few scripts. The structure of the deal....sanofi in charge of sales. screencast.com/t/Kte8MsYfsJZ Then AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015 easy to do the same old when the practice guidelines are so established. Cost for the established treatments established. Sanofi in charge of price. Sanofi in charge of studies. Sanofi in charge of approvals in other countries. Sanofi in charge of insurance coverage.
------------------------------------------------------------------------------------------------------------------------------------------------------------
Why was DeSisto hired? Now it looks like something hit the wall and a new leadership was needed. I was hoping Al took over because there was a deal in the works and he holds the shares.
The gate keepers on this drug are the physicians and the insurance companies.
------------------------------------------------------------------------------------------------------------------------------------------------------------------------
On a different note Sam said he feels so much better. He got used to living on subq insulin. He feels better now, his blood sugars more normalized. and he can eat.
|
|
|
Post by EveningOfTheDay on Jan 3, 2016 10:48:11 GMT -5
Peppy I also assume both Matt and Hakan were surprised not to see a faster pick up in RXs, but precisely that should be the reason for them to step aside. Hakan, one way or another, has done just that, but, unless proven wrong, I think Matt deserves a similar fortune. If things are not what they appear none of this matters much, but if we are truly in as much trouble as it seems Matt is certainly responsible for a big part of it. IMO.
|
|
|
Post by mnholdem on Jan 3, 2016 11:13:22 GMT -5
While not being at all certain what or when Duane's first big announcement will be (though hoping is a TS deal in Jan), is it fair to think that Matt's job may be on the line due to all that has transpired since notes in summer? Talk about wiping slate clean. Any finance guys wanna chime in on likelihood? Why would DeSisto have a problem with Matt? It seems to me that Matt Pfeffer can now focus on his job as CFO. Many companies assign their CFO to the additional responsibility of Investor Relations Officer, a secondary role that Matt currently performs - poorly IMO. I think Matt's CFO job is secure, and while I like our new CEO's public speaking skills, I'd really like Duane to seriously consider hiring a more seasoned Investor Relations executive for presentations at investor conferences and to revamp the corporate web site.
|
|
|
Post by bradleysbest on Jan 3, 2016 11:40:57 GMT -5
Maybe we are getting ahead of ourselves just a bit too much. I am not happy with the share price but I think we need to give DeSisto the opportunity to settle in and take a look at what is going on before making any hasty decisions. If after taking a look at things and he decides to move some people out and bring some fresh blood in then I am all for it. My main goal is for him to get SNY to either release their vision for Afrezza or and/or execute that vision! The silence between both MNKD and SNY hurts as the share price has continually dropped. Now if the share price was RISING I would not have a problem with their silence....
|
|